scispace - formally typeset
Open AccessJournal ArticleDOI

SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern

Reads0
Chats0
About
This article is published in Ndt Plus.The article was published on 2021-07-06 and is currently open access. It has received 5 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis

TL;DR: Although the authors found both mRNA vaccines were effective, Moderna/mRNA-1273 had a lower incidence rate of breakthrough infections, Immunocompromised and male individuals were among the highest risk groups experiencing breakthrough infections.
Journal ArticleDOI

Surfing the Waves: Differences in Hospitalised COVID-19 Patients across 4 Variant Waves in a Belgian University Hospital

TL;DR: In this paper , the authors compared clinical data and severity scores, using the National Institute of Health (NIH) severity score, from all patients admitted for COVID-19 during four SARS-CoV-2 variant waves.
Journal ArticleDOI

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients

TL;DR: In this paper , the authors evaluated the clinical protection by vaccines (breakthrough infections, deaths, and hospitalizations) in kidney transplant recipients (KTRs) with COVID-19 breakthrough infections for whom patient-level data were available in PubMed and Web of Science.
Journal ArticleDOI

A narrative review of vaccine-induced thrombotic thrombocytopenia in organ donation and transplantation: Current evidence and implications

TL;DR: In this article , a multidisciplinary approach to assess all benefits and risks before accepting or discarding organs is proposed, where the organs should undergo deliberate examination for functionality by clinical, laboratory, and radiological parameters.
Journal ArticleDOI

Tozinameran

- 01 Jun 2023 - 
References
More filters
Journal ArticleDOI

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

TL;DR: This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA vaccine is effective for a wide range of Covid-19–related outcomes, a finding consistent with that of the randomized trial.
Journal ArticleDOI

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.

TL;DR: In this article, the antibody response following the second dose of SARS-CoV2 mRNA vaccine in recipients of solid organ transplants was measured using a follow-up study.
Journal ArticleDOI

Severe consequences of COVID-19 infection among vaccinated kidney transplant recipients

TL;DR: The COVID-19 pandemic has reached its second year and the global worldwide vaccination effort is underway, placing the elderly and higher risk people in higher priority of receiving immunization as discussed by the authors.